Breaking News Instant updates and real-time market news.

RCI

Rogers Communications

$53.15 /

-0.14 (-0.26%)

07:04
04/18/19
04/18
07:04
04/18/19
07:04

Rogers Communications reports Q1 adj. EPS C$0.78 vs. C$0.90 last year

Reports Q1 revenue C$3.59B vs. C$3.63B last year.

  • 18

    Apr

  • 14

    May

  • 23

    May

RCI Rogers Communications
$53.15 /

-0.14 (-0.26%)

02/06/19 TD Securities
Rogers Communications removed from Action List at TD Securities
02/06/19 TD Securities
Rogers Communications downgraded to Buy from Action List Buy at TD Securities
01/25/19 Macquarie
Rogers Communications downgraded to Neutral from Outperform at Macquarie
01/07/19
Canaccord downgrades Rogers to Hold on expected wireless momentum cooling

TODAY'S FREE FLY STORIES

Hot Stocks
Indiva expands distribution network to Yukon Territory » 07:05
07/09/20
07/09
07:05
07/09/20
07:05
NDVAF

INDIVA

$0.00 /

+ (+0.00%)

Indiva announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDVAF INDIVA
$0.00 /

+ (+0.00%)

Hot Stocks
Akcea Therapeutics appoints William Andrews as chief medical officer » 07:05
07/09/20
07/09
07:05
07/09/20
07:05
AKCA

Akcea Therapeutics

$13.88 /

-0.18 (-1.28%)

, IONS

Ionis Pharmaceuticals

$60.90 /

-0.39 (-0.64%)

, ACER

Acer Therapeutics

$3.21 /

+0.07 (+2.23%)

Akcea Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AKCA Akcea Therapeutics
$13.88 /

-0.18 (-1.28%)

IONS Ionis Pharmaceuticals
$60.90 /

-0.39 (-0.64%)

ACER Acer Therapeutics
$3.21 /

+0.07 (+2.23%)

AKCA Akcea Therapeutics
$13.88 /

-0.18 (-1.28%)

01/22/20 Stifel
Akcea LICA data look 'solid,' as expected, says Stifel
10/08/19 BMO Capital
Akcea Therapeutics price target lowered to $39 from $43 at BMO Capital
10/07/19 Stifel
Pfizer deal a 'solid, unexpected' win for Akcea Therapeutics, says Stifel
10/07/19
Akcea Therapeutics upgraded to Outperform on Pfizer partnership at Wells Fargo
IONS Ionis Pharmaceuticals
$60.90 /

-0.39 (-0.64%)

06/05/20 Citi
Ionis Pharmaceuticals price target raised to $80 from $71 at Citi
05/12/20 RBC Capital
Ionis Pharmaceuticals initiated with an Outperform at RBC Capital
04/22/20 Jefferies
Jefferies remains cautious on Ionis after report from partner Biogen
03/26/20 Cantor Fitzgerald
Ionis Pharmaceuticals price target lowered to $56 from $65 at Cantor Fitzgerald
ACER Acer Therapeutics
$3.21 /

+0.07 (+2.23%)

AKCA Akcea Therapeutics
$13.88 /

-0.18 (-1.28%)

IONS Ionis Pharmaceuticals
$60.90 /

-0.39 (-0.64%)

ACER Acer Therapeutics
$3.21 /

+0.07 (+2.23%)

ACER Acer Therapeutics
$3.21 /

+0.07 (+2.23%)

IONS Ionis Pharmaceuticals
$60.90 /

-0.39 (-0.64%)

General news
FX Update: The dollar pared declines » 07:05
07/09/20
07/09
07:05
07/09/20
07:05

FX Update: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
New Oriental Education price target raised to $160 from $150 at Nomura Instinet » 07:04
07/09/20
07/09
07:04
07/09/20
07:04
EDU

New Oriental Education

$141.67 /

+3.84 (+2.79%)

Nomura Instinet analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDU New Oriental Education
$141.67 /

+3.84 (+2.79%)

EDU New Oriental Education
$141.67 /

+3.84 (+2.79%)

06/30/20 Goldman Sachs
New Oriental Education price target raised to $149 from $145 at Goldman Sachs
04/22/20 CLSA
New Oriental Education upgraded to Buy from Outperform at CLSA
04/22/20 CLSA
New Oriental Education upgraded to Buy from Outperform at CLSA
04/22/20 Citi
New Oriental Education negatives mostly priced in, says Citi
EDU New Oriental Education
$141.67 /

+3.84 (+2.79%)

EDU New Oriental Education
$141.67 /

+3.84 (+2.79%)

Hot Stocks
LiveXLive Media enters multi-year partnership with Corona Electric Beach » 07:04
07/09/20
07/09
07:04
07/09/20
07:04
LIVX

LiveXLive Media

$4.26 /

-0.28 (-6.17%)

LiveXLive Media announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LIVX LiveXLive Media
$4.26 /

-0.28 (-6.17%)

LIVX LiveXLive Media
$4.26 /

-0.28 (-6.17%)

06/19/20 Alliance Global Partners
LiveXLive Media price target raised to $6 from $5.50 at Alliance Global Partners
06/19/20 Ladenburg
LiveXLive Media price target raised to $5.75 from $4.50 at Ladenburg
05/11/20 Alliance Global Partners
LiveXLive Media price target raised to $5.50 from $4 at Alliance Global Partners
04/16/20 Ladenburg
LiveXLive Media price target raised to $3.50 from $2.50 at Ladenburg
LIVX LiveXLive Media
$4.26 /

-0.28 (-6.17%)

LIVX LiveXLive Media
$4.26 /

-0.28 (-6.17%)

LIVX LiveXLive Media
$4.26 /

-0.28 (-6.17%)

Hot Stocks
Orchard Therapeutics, MolMed extend collaboration for five years » 07:03
07/09/20
07/09
07:03
07/09/20
07:03
ORTX

Orchard Therapeutics

$5.20 /

-0.01 (-0.19%)

Orchard Therapeutics and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORTX Orchard Therapeutics
$5.20 /

-0.01 (-0.19%)

ORTX Orchard Therapeutics
$5.20 /

-0.01 (-0.19%)

05/22/20 JPMorgan
Orchard Therapeutics price target lowered to $17 from $26 at JPMorgan
09/17/19
Fly Intel: Top five analyst initiations
09/17/19
Guggenheim bullish on Orchard Therapeutics, initiates with a Buy
09/17/19 Guggenheim
Orchard Therapeutics initiated with a Buy at Guggenheim
ORTX Orchard Therapeutics
$5.20 /

-0.01 (-0.19%)

ORTX Orchard Therapeutics
$5.20 /

-0.01 (-0.19%)

Recommendations
SAP price target raised to $150 from $142 at RBC Capital » 07:02
07/09/20
07/09
07:02
07/09/20
07:02
SAP

SAP

$146.75 /

+2.75 (+1.91%)

RBC Capital analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

06:23 Today JMP Securities
SAP price target raised to $165 from $150 at JMP Securities
07/08/20 UBS
SAP price target raised to EUR 142 from EUR 118 at UBS
06/16/20 Oppenheimer
SAP price target raised to $137 from $115 at Oppenheimer
06/16/20 RBC Capital
SAP price target raised to $142 from $117 at RBC Capital
SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

SAP SAP
$146.75 /

+2.75 (+1.91%)

Hot Stocks
Kymera Therapeutics, Sanofi enter strategic collaboration » 07:02
07/09/20
07/09
07:02
07/09/20
07:02
SNY

Sanofi

$51.54 /

+0.14 (+0.27%)

Kymera Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$51.54 /

+0.14 (+0.27%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
SNY Sanofi
$51.54 /

+0.14 (+0.27%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

Recommendations
Twitter shares overreacted to paid service potential, says Citi » 07:01
07/09/20
07/09
07:01
07/09/20
07:01
TWTR

Twitter

$35.40 /

+2.42 (+7.34%)

Twitter shares rose 7%…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$35.40 /

+2.42 (+7.34%)

TWTR Twitter
$35.40 /

+2.42 (+7.34%)

07/08/20 Rosenblatt
Rosenblatt says 'highly unlikely' Twitter considering paid subscription tiers
06/30/20 Morgan Stanley
Morgan Stanley says buy Facebook amid boycott-driven weakness
06/29/20 Stifel
Stifel says Facebook sales won't be materially hurt unless ad boycott broadens
06/29/20 JPMorgan
Facebook estimates not at risk from ad boycott, says JPMorgan
TWTR Twitter
$35.40 /

+2.42 (+7.34%)

TWTR Twitter
$35.40 /

+2.42 (+7.34%)

TWTR Twitter
$35.40 /

+2.42 (+7.34%)

TWTR Twitter
$35.40 /

+2.42 (+7.34%)

Downgrade
Janney Montgomery Scott downgrades 'consensus long' Cedar Fair to Neutral » 07:01
07/09/20
07/09
07:01
07/09/20
07:01
FUN

Cedar Fair

$27.60 /

-0.28 (-1.00%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUN Cedar Fair
$27.60 /

-0.28 (-1.00%)

FUN Cedar Fair
$27.60 /

-0.28 (-1.00%)

06:56 Today Janney Montgomery Scott
Janney Montgomery Scott upgrades Six Flags to Buy in theme park preference shift
06:13 Today Janney Montgomery Scott
Cedar Fair downgraded to Neutral from Buy at Janney Montgomery Scott
06/15/20 B. Riley FBR
B. Riley FBR upgrades Cedar Fair to Buy with 25% potential upside
06/15/20 B. Riley FBR
Cedar Fair upgraded to Buy from Neutral at B. Riley FBR
FUN Cedar Fair
$27.60 /

-0.28 (-1.00%)

FUN Cedar Fair
$27.60 /

-0.28 (-1.00%)

Syndicate
Nkarta raises IPO price range to $16.00-$17.00, increases shares » 06:58
07/09/20
07/09
06:58
07/09/20
06:58
NKTX

Nkarta

$0.00 /

+ (+0.00%)

Nkarta's IPO deal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 10
    Jul
NKTX Nkarta
$0.00 /

+ (+0.00%)

Upgrade
Janney Montgomery Scott upgrades Six Flags to Buy in theme park preference shift » 06:56
07/09/20
07/09
06:56
07/09/20
06:56
SIX

Six Flags

$19.50 /

+0.44 (+2.31%)

, FUN

Cedar Fair

$27.60 /

-0.28 (-1.00%)

, SEAS

SeaWorld

$16.19 /

+0.645 (+4.15%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIX Six Flags
$19.50 /

+0.44 (+2.31%)

FUN Cedar Fair
$27.60 /

-0.28 (-1.00%)

SEAS SeaWorld
$16.19 /

+0.645 (+4.15%)

SIX Six Flags
$19.50 /

+0.44 (+2.31%)

06:11 Today Janney Montgomery Scott
Six Flags upgraded to Buy from Neutral at Janney Montgomery Scott
06/15/20 B. Riley FBR
B. Riley FBR upgrades Six Flags ahead of China development plans
06/15/20 B. Riley FBR
Six Flags upgraded to Buy from Neutral at B. Riley FBR
06/09/20 B. Riley FBR
Six Flags price target raised to $27 from $18.50 at B. Riley FBR
FUN Cedar Fair
$27.60 /

-0.28 (-1.00%)

06:13 Today Janney Montgomery Scott
Cedar Fair downgraded to Neutral from Buy at Janney Montgomery Scott
06/15/20 B. Riley FBR
B. Riley FBR upgrades Cedar Fair to Buy with 25% potential upside
06/15/20 B. Riley FBR
Cedar Fair upgraded to Buy from Neutral at B. Riley FBR
06/11/20 Stifel
Cedar Fair price target raised to $44 from $34 at Stifel
SEAS SeaWorld
$16.19 /

+0.645 (+4.15%)

06:12 Today Janney Montgomery Scott
SeaWorld downgraded to Neutral from Buy at Janney Montgomery Scott
06/09/20 B. Riley FBR
SeaWorld price target raised to $29 from $17 at B. Riley FBR
06/04/20
Fly Intel: Top five analyst upgrades
06/04/20 Citi
Citi upgrades SeaWorld to Buy on 'compelling' risk/reward
SIX Six Flags
$19.50 /

+0.44 (+2.31%)

FUN Cedar Fair
$27.60 /

-0.28 (-1.00%)

SEAS SeaWorld
$16.19 /

+0.645 (+4.15%)

SIX Six Flags
$19.50 /

+0.44 (+2.31%)

SEAS SeaWorld
$16.19 /

+0.645 (+4.15%)

SIX Six Flags
$19.50 /

+0.44 (+2.31%)

FUN Cedar Fair
$27.60 /

-0.28 (-1.00%)

SEAS SeaWorld
$16.19 /

+0.645 (+4.15%)

SIX Six Flags
$19.50 /

+0.44 (+2.31%)

SEAS SeaWorld
$16.19 /

+0.645 (+4.15%)

Downgrade
Alumina downgraded to Neutral from Buy at Citi » 06:54
07/09/20
07/09
06:54
07/09/20
06:54
AWCMY

Alumina

$0.00 /

+ (+0.00%)

Citi analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AWCMY Alumina
$0.00 /

+ (+0.00%)

05/07/20 Credit Suisse
Alumina downgraded to Neutral from Outperform at Credit Suisse
03/23/20 Jefferies
Alumina upgraded to Buy from Underperform at Jefferies
03/23/20 Macquarie
Alumina upgraded to Outperform from Underperform at Macquarie
03/19/20 Goldman Sachs
Alumina upgraded to Buy from Neutral at Goldman Sachs
Hot Stocks
Endeavour Silver produces 596,545 silver ounces in Q2 » 06:53
07/09/20
07/09
06:53
07/09/20
06:53
EXK

Endeavour Silver

$2.44 /

+0.075 (+3.18%)

Endeavour Silver reports…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXK Endeavour Silver
$2.44 /

+0.075 (+3.18%)

EXK Endeavour Silver
$2.44 /

+0.075 (+3.18%)

02/26/20 Noble Capital
Endeavour Silver downgraded to Market Perform from Outperform at Noble Capital
11/07/19 GMP Securities
Endeavour Silver downgraded to Hold from Buy at GMP Securities
09/23/19 Noble Capital
Endeavour Silver upgraded to Outperform from Market Perform at Noble Capital
EXK Endeavour Silver
$2.44 /

+0.075 (+3.18%)

EXK Endeavour Silver
$2.44 /

+0.075 (+3.18%)

Hot Stocks
The Buckle reports June net sales up 28.6% y-o-y » 06:53
07/09/20
07/09
06:53
07/09/20
06:53
BKE

The Buckle

$16.89 /

+0.69 (+4.26%)

The Buckle reported total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKE The Buckle
$16.89 /

+0.69 (+4.26%)

BKE The Buckle
$16.89 /

+0.69 (+4.26%)

Upgrade
Kubota upgraded to Neutral from Sell at Citi » 06:53
07/09/20
07/09
06:53
07/09/20
06:53
KUBTY

Kubota

$0.00 /

+ (+0.00%)

Citi analyst Graeme…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KUBTY Kubota
$0.00 /

+ (+0.00%)

07/02/20 SMBC Nikko
Kubota upgraded to Outperform from Neutral at SMBC Nikko
04/20/20 Citi
Kubota downgraded to Sell from Buy at Citi
08/28/19 Goldman Sachs
Kubota upgraded to Neutral from Sell at Goldman Sachs
Hot Stocks
Osmotica Pharmaceuticals receives FDA approval for Upneeq » 06:52
07/09/20
07/09
06:52
07/09/20
06:52
OSMT

Osmotica Pharmaceuticals

$6.34 /

-0.06 (-0.94%)

Osmotica Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSMT Osmotica Pharmaceuticals
$6.34 /

-0.06 (-0.94%)

OSMT Osmotica Pharmaceuticals
$6.34 /

-0.06 (-0.94%)

03/23/20 Wells Fargo
Wells Fargo downgrades Osmotica to Equal Weight, halves price target to $4
03/23/20 Wells Fargo
Osmotica Pharmaceuticals downgraded to Equal Weight from Overweight at Wells Fargo
03/18/20 SunTrust
Osmotica Pharmaceuticals initiated with a Buy at SunTrust
03/06/20
Fly Intel: Top five analyst initiations
OSMT Osmotica Pharmaceuticals
$6.34 /

-0.06 (-0.94%)

  • 09
    Jan
OSMT Osmotica Pharmaceuticals
$6.34 /

-0.06 (-0.94%)

Hot Stocks
Coty announces additions to Executive Committee » 06:51
07/09/20
07/09
06:51
07/09/20
06:51
COTY

Coty

$4.30 /

+0.025 (+0.59%)

Coty is adding three…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COTY Coty
$4.30 /

+0.025 (+0.59%)

COTY Coty
$4.30 /

+0.025 (+0.59%)

06/30/20 Jefferies
Jefferies says Coty 'needs to defy odds' for KKW deal to deliver sustained value
05/13/20 Exane BNP Paribas
Coty downgraded to Neutral from Outperform at Exane BNP Paribas
05/13/20 Exane BNP Paribas
Coty downgraded to Neutral from Outperform at Exane BNP Paribas
05/12/20 Deutsche Bank
Coty price target lowered to $6 from $8 at Deutsche Bank
COTY Coty
$4.30 /

+0.025 (+0.59%)

COTY Coty
$4.30 /

+0.025 (+0.59%)

COTY Coty
$4.30 /

+0.025 (+0.59%)

COTY Coty
$4.30 /

+0.025 (+0.59%)

Hot Stocks
Document Security: Impact Biomedical announces 'positive' results from Equivir » 06:50
07/09/20
07/09
06:50
07/09/20
06:50
DSS

Document Security

$6.45 /

+0.3 (+4.88%)

Document Security…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DSS Document Security
$6.45 /

+0.3 (+4.88%)

DSS Document Security
$6.45 /

+0.3 (+4.88%)

06/24/20 Aegis
Document Security assumed with a Buy at Aegis
10/10/19 Aegis
Document Security initiated with a Buy rating at Aegis
DSS Document Security
$6.45 /

+0.3 (+4.88%)

  • 02
    Jul
  • 22
    May
  • 21
    Feb
DSS Document Security
$6.45 /

+0.3 (+4.88%)

Recommendations
Allstate acquisition of National an incremental positive, says Citi » 06:49
07/09/20
07/09
06:49
07/09/20
06:49
ALL

Allstate

$88.20 /

-4.38 (-4.73%)

, NGHC

National General

$33.73 /

+13.29 (+65.02%)

Citi analyst Suneet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALL Allstate
$88.20 /

-4.38 (-4.73%)

NGHC National General
$33.73 /

+13.29 (+65.02%)

ALL Allstate
$88.20 /

-4.38 (-4.73%)

06:20 Today JMP Securities
National General downgraded to Market Perform from Outperform at JMP Securities
07/08/20 William Blair
National General downgraded to Market Perform from Outperform at William Blair
07/08/20 B. Riley FBR
National General price target raised to $34.50 from $28 at B. Riley FBR
06/25/20
Fly Intel: Top five analyst upgrades
NGHC National General
$33.73 /

+13.29 (+65.02%)

06:20 Today JMP Securities
National General downgraded to Market Perform from Outperform at JMP Securities
06:16 Today B. Riley FBR
National General downgraded to Neutral from Buy at B. Riley FBR
07/08/20 William Blair
National General downgraded to Market Perform from Outperform at William Blair
07/08/20 B. Riley FBR
National General price target raised to $34.50 from $28 at B. Riley FBR
ALL Allstate
$88.20 /

-4.38 (-4.73%)

NGHC National General
$33.73 /

+13.29 (+65.02%)

ALL Allstate
$88.20 /

-4.38 (-4.73%)

NGHC National General
$33.73 /

+13.29 (+65.02%)

Hot Stocks
AstraZeneca reports Brilinta sNDA accepted, granted FDA Priority Review » 06:49
07/09/20
07/09
06:49
07/09/20
06:49
AZN

AstraZeneca

$54.19 /

+0.7 (+1.31%)

AstraZeneca announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

06/24/20 Oddo BHF
AstraZeneca downgraded to Reduce from Buy at Oddo BHF
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/10/20 Cowen
AstraZeneca price target raised to $60 from $55 at Cowen
06/10/20 Guggenheim
Merck's bladder cancer failure boosts strategic value of Padcev, says Guggenheim
AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

Hot Stocks
International Game awarded mangement system contract at Emerald Queen casino » 06:48
07/09/20
07/09
06:48
07/09/20
06:48
IGT

International Game

$9.84 /

-0.105 (-1.06%)

International Game…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IGT International Game
$9.84 /

-0.105 (-1.06%)

IGT International Game
$9.84 /

-0.105 (-1.06%)

05/21/20
Fly Intel: Top five analyst downgrades
05/21/20 Societe Generale
International Game downgraded to Hold on 'long' recovery at Societe Generale
05/21/20 Credit Suisse
International Game assumed with an Underperform from Neutral at Credit Suisse
05/21/20 Societe Generale
International Game downgraded to Hold from Buy at Societe Generale
IGT International Game
$9.84 /

-0.105 (-1.06%)

IGT International Game
$9.84 /

-0.105 (-1.06%)

IGT International Game
$9.84 /

-0.105 (-1.06%)

Recommendations
Avita Medical price target raised to $41 from $8 at BTIG » 06:48
07/09/20
07/09
06:48
07/09/20
06:48
RCEL

Avita Medical

$29.76 /

-0.05 (-0.17%)

BTIG analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCEL Avita Medical
$29.76 /

-0.05 (-0.17%)

RCEL Avita Medical
$29.76 /

-0.05 (-0.17%)

07/06/20 Oppenheimer
Avita Medical price target raised to $45 from $9 at Oppenheimer
04/20/20 Oppenheimer
Avita Medical initiated with an Outperform at Oppenheimer
03/05/20 Lake Street
Avita Medical pullback brings buying opportunity, says Lake Street
03/03/20 BTIG
Avita Medical initiated with a Buy at BTIG
RCEL Avita Medical
$29.76 /

-0.05 (-0.17%)

Hot Stocks
Pentair names Steve Pilla as EVP, Chief Supply Chain Officer » 06:48
07/09/20
07/09
06:48
07/09/20
06:48
PNR

Pentair

$36.62 /

+0.15 (+0.41%)

Pentair announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNR Pentair
$36.62 /

+0.15 (+0.41%)

PNR Pentair
$36.62 /

+0.15 (+0.41%)

06:13 Today BofA
Pentair double-upgraded to Buy from Underperform at BofA
06:02 Today BofA
Pentair upgraded to Buy from Underperform at BofA
05/15/20 Vertical Research
Pentair upgraded to Buy from Hold at Vertical Research
03/27/20 Oppenheimer
Pentair resilience should stand out in 2020, says Oppenheimer
PNR Pentair
$36.62 /

+0.15 (+0.41%)

Hot Stocks
Merck: FDA grants priority review for sBLA for Keytruda » 06:47
07/09/20
07/09
06:47
07/09/20
06:47
MRK

Merck

$77.87 /

-0.77 (-0.98%)

Merck announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$77.87 /

-0.77 (-0.98%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
MRK Merck
$77.87 /

-0.77 (-0.98%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.